We offer a global full-service range of safety testing and regulatory consultancy capabilities to support the human and environmental risk assessments for both chemical testing and crop protection products.
Small and emerging biotechs often rely on the support of a contract research organization (CRO) in early clinical research, but how can both parties ensure they are forming a flexible partnership that can consistently handle the ever-increasing complexity of early clinical development?
Technology is growing at a fast clip in patient service hubs. Filling out information online is becoming the norm for increasingly tech-savvy patients and HCPs. Automation is providing speed, cost reduction and greater accessibility to patient assistance programs. We can see that technology is a significant resource, but it's not a silver-bullet solution.
As the rate of cell and gene therapy development increases, Labcorp Drug Development has continued to invest in the technology, capacity and expertise globally to support the evolving and complex analytical needs of our clients.
Learn how an integrated approach to the use of mobile clinical services involving site support services, central pharmacy services and home visits by clinicians can make the trial both more patient-centric and attractive to investigator sites, potentially giving a competitive advantage in the competitive enrollment process.
There are many patient communities across various races and ethnicities that are often underrepresented in clinical trials, which creates significant gaps in the safety and efficacy data of new therapies.
Labcorp Drug Development offers a comprehensive solution to clients seeking to harness the power of genomic- and proteomic-based profiling to support clinical development programs.
Hear Kathy Landshulz, Therapeutic Area Lead, Biomarker Solution Center, Labcorp Oncology, keynote presentation from the World CDx US 2022 conference, "Practical Strategies for Implementing an Effective Neurodegenerative Biomarker Program into Your Clinical Trial and Diagnostic Transition."
The presentation covers deploying the right biomarkers, platforms
Listen to Maryland Franklin, PhD, Vice President and Enterprise Head of Cell & Gene Therapy, Labcorp Drug Development, focus on addressing the complexity of long-term follow up for cell and gene therapy with a patient-guided approach in her presentation, Taking the Long View: Addressing the Unique Challenge of Long-Term Follow Up for Cell & Gene Th
